Wei B Y, Holford-Strevens V, Carter B G, Sehon A H
Immunology. 1984 Apr;51(4):687-96.
The i.p. injection of 1 microgram of TM3-OA or TM9-OA with 1 mg of A1(OH)3 into B6D2F1 mice elicited the production of antibodies of the IgE and other classes to the trimellityl (TM) group and ovalbumin (OA). The induction of anti-TM antibodies belonging to the IgE and other immunoglobulin classes was specifically suppressed by the administration of tolerogenic conjugates prepared by coupling trimellitic anhydride (TMA) to the hydrophilic non-immunogenic polymer, polyvinyl alcohol (PVA), prior to immunization with TM-OA conjugates. More importantly, established anti-TM responses were also suppressed by these TM-PVA conjugates. By contrast, however, treatment with TM-PVA conjugates did not affect either the primary or the established anti-OA antibody response. The tolerogenic effects of the PVA conjugates were dose-dependent and appeared also to be dependent on the epitope density. Treatment with these conjugates also prevented immunized mice from showing any symptoms of systemic anaphylaxis on challenge with polyvalent TM-protein conjugates. These findings indicate that these conjugates may have the potential of useful therapeutic agents for the treatment of TMA-induced pulmonary hypersensitivity diseases.
将1微克的偏苯三酸酐(TM3 - OA)或偏苯三酸酐(TM9 - OA)与1毫克氢氧化铝经腹腔注射到B6D2F1小鼠体内,可引发针对偏苯三酸(TM)基团和卵清蛋白(OA)的IgE及其他类别抗体的产生。在用TM - OA偶联物免疫之前,通过将偏苯三酸酐(TMA)与亲水性非免疫原性聚合物聚乙烯醇(PVA)偶联制备的耐受性偶联物给药,可特异性抑制属于IgE和其他免疫球蛋白类别的抗TM抗体的诱导。更重要的是,这些TM - PVA偶联物也抑制了已建立的抗TM反应。然而,相比之下,用TM - PVA偶联物处理对初次或已建立的抗OA抗体反应均无影响。PVA偶联物的耐受性作用呈剂量依赖性,且似乎还取决于表位密度。用这些偶联物处理还可防止免疫小鼠在用多价TM - 蛋白偶联物激发时出现任何全身性过敏反应症状。这些发现表明,这些偶联物可能具有作为治疗TMA诱导的肺部超敏性疾病的有用治疗剂的潜力。